Winton Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-69,536
| Closed | -$2.25M | – | 725 |
|
|
2023
Q4 | $2.25M | Buy |
69,536
+57,438
| +475% | +$1.86M | 0.16% | 101 |
|
|
2023
Q3 | $396K | Sell |
12,098
-695
| -5% | -$22.8K | 0.03% | 367 |
|
|
2023
Q2 | $450K | Sell |
12,793
-25,590
| -67% | -$901K | 0.04% | 371 |
|
|
2023
Q1 | $1.25M | Buy |
38,383
+16,309
| +74% | +$532K | 0.08% | 363 |
|
|
2022
Q4 | $1.22M | Buy |
22,074
+5,350
| +32% | +$295K | 0.08% | 353 |
|
|
2022
Q3 | $741K | Buy |
16,724
+6,017
| +56% | +$267K | 0.05% | 517 |
|
|
2022
Q2 | $522K | Buy |
+10,707
| New | +$522K | 0.03% | 683 |
|
|
2022
Q1 | – | Sell |
-6,932
| Closed | -$296K | – | 1049 |
|
|
2021
Q4 | $296K | Buy |
+6,932
| New | +$296K | 0.02% | 836 |
|